Summit Therapeutics PLC
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 84.3% | 29.3% | 424.4% | -30.8% | 37.2% | -918.6% | -0.4% | 116,580,824,319,692.6% | -18.7% | -3.4% | 0.0% | 24.7% | 0.0% | 100.4% | – | – | – | – | – | – | – | – | – | 21.7% | – | 84,539.0% | – | 200.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 82.5% | 100.0% | 21,994.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -84,397.2% | – | -100.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 277.3% | 291.4% | 139.1% | 225.0% | 215.3% | 290.5% | 19.7% | 1,214.2% | 879.1% | 175.7% | 3,322.5% | 7,216.0% | 6,723.7% | 3,985.2% | 6,753.5% | 7,983.6% | 7,583.4% | 7,061.6% | 9,572.4% | 41,970.2% | 1,523.5% | 9,206.0% | 8,222.4% | 3,833.2% | 7,749.6% | 631,972.5% | – | 3,166.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 162.8% | 140.9% | 52.4% | 60.0% | 60.1% | 68.9% | 6.1% | 690.0% | 337.7% | 47.8% | 664.7% | 1,369.2% | 1,812.9% | 1,102.5% | 3,117.1% | 3,396.5% | 3,782.3% | 1,643.2% | 2,179.7% | 10,498.2% | 432.5% | 3,099.6% | 2,663.6% | 2,950.2% | 2,533.2% | 889,173.5% | – | 2,116.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 452.5% | 432.2% | 191.5% | 257.5% | 256.3% | 270.2% | 35.5% | 1,485.8% | 1,156.7% | 223.5% | 2,030.9% | 4,422.4% | 4,282.5% | 2,982.7% | 9,139.4% | 9,133.0% | 9,459.7% | 6,346.5% | 8,914.1% | 41,731.6% | 1,588.6% | 10,477.3% | 8,963.2% | 5,500.9% | 7,800.0% | 2,381,806.8% | – | 5,292.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -352.5% | -329.1% | -90.3% | -157.5% | -170.1% | -170.2% | 64.5% | -1,385.8% | 729.3% | -123.5% | -1,930.9% | -6,096.9% | -4,182.5% | -2,882.7% | -9,039.4% | -11,192.6% | -14,536.4% | -6,246.5% | -8,814.1% | -41,631.6% | -1,488.6% | -10,377.3% | -8,863.2% | -5,400.9% | -7,700.0% | -2,381,806.8% | – | -5,292.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16.6% | 16.8% | 6.1% | 9.0% | 5.2% | 4.9% | 0.4% | 8.9% | 7.4% | 1.6% | 24.5% | 61.4% | 67.5% | 20.0% | 32.4% | 32.2% | 296.6% | 219.3% | 405.7% | 524.2% | 11.6% | 566.8% | 79.9% | 338.2% | 351.3% | 411,914.9% | – | 1,070.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -364.9% | -343.3% | -95.4% | -70.8% | -175.2% | -175.0% | 71.5% | -1,394.0% | -508.9% | -124.7% | -1,954.6% | -6,158.3% | -4,233.1% | -1,876.2% | -9,071.8% | -11,275.7% | -14,512.9% | -10,025.1% | -9,108.4% | -42,835.1% | -1,497.3% | -10,796.5% | -8,558.8% | -7,136.6% | -9,720.5% | -2,256,257.2% | – | -4,931.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -79.1% | -67.5% | -26.6% | 44.6% | -24.4% | -24.4% | 1.3% | -188.9% | -81.6% | -22.0% | -338.2% | -1,051.3% | 75.0% | 17.0% | -112.4% | -139.2% | -1,864.2% | -15.5% | -2,641.4% | -10,202.2% | -392.7% | -1,890.0% | -399.9% | -419.6% | -621.3% | -112,482.3% | – | 16.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -285.0% | -275.5% | -69.1% | -26.2% | -150.8% | -150.6% | 54.5% | -1,205.1% | -486.0% | -107.9% | -1,616.5% | -4,284.0% | -4,308.1% | -1,893.2% | -8,959.4% | -8,987.7% | -9,802.8% | -7,319.5% | -9,108.4% | -42,835.1% | -1,497.3% | -10,796.5% | -8,558.8% | -7,136.6% | -9,720.5% | -2,256,257.2% | – | -4,931.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -351.7% | -330.8% | -90.7% | -183.9% | -160.6% | -162.8% | 53.5% | -1,334.5% | -1,109.1% | -116.3% | – | -4,031.6% | -3,943.9% | -2,778.4% | -9,039.4% | -8,821.8% | -8,665.7% | -5,998.9% | -8,639.6% | -41,702.1% | -1,459.9% | -10,099.0% | -8,352.1% | -6,657.5% | -9,228.3% | -1,500,847.0% | – | -3,845.7% | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.